Skip to content
GradedGrading live · 2026
LongevityGraded
Menu

Graded review

Wellspring Longevity Clinic Reviews: Pricing You Have to Dig For

Wellspring's own "Pricing" FAQ gives no number — just a comparison to retail. Its pharmacy is named, but only if you find the right FAQ answer.

Researched & graded by Tom Vance · Lead Reviews Analyst
Last graded
On this page
A

Top of the scorecard

Grade A

CoreAge Rx

Doctor-reviewed longevity peptides and NAD+ with one published per-protocol price and built-in human support.

$93–$99/mo (12-mo plan)

Paid placement — we may earn a commission, at no extra cost to you.

Check availability
Pricing
Flat monthly, no membership
Pharmacy
503A compounding pharmacy
Labs
No labs required
Consult
Clinician review included
Support
1:1 nurse + dietitian

Affiliate partners are listed first on the scorecard. Every letter grade is computed from the published rubric and cannot see who pays us.

B

Also on the scorecard

Grade B

Peter MD

A broad physician-prescribed menu — sermorelin and NAD+ alongside tirzepatide, semaglutide, TRT and hair loss — under one account, with pricing that is real but mostly tiered by supply length rather than a flat monthly rate.

Sermorelin ~$195/mo (12-wk) · NAD+ ~$147–184/mo · TRT $139/mo

Paid placement — we may earn a commission, at no extra cost to you.

Visit Peter MD

Sermorelin, NAD+ and GLP1+B12 are sold as a lump sum for an estimated multi-week supply (e.g. NAD+'s $369 covers an "estimated" 8–10 weeks) rather than billed monthly, so the effective monthly cost is a range, not a figure you can pin down. Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.

The one-sentence version

Wellspring Longevity Clinic's dedicated FAQ entry titled "Pricing" does not contain a price. It reads: "Many treatment plans include a free consultation. If a prescription is issued, you can purchase your medication at significantly lower costs than traditional retail prices—often more affordable than your local pharmacy." The actual numbers live only on individual product pages, each carrying an unresolved "Starts at $X" figure — NAD+ from $249, Sermorelin from $349. Its GLP-1 line is marketed only as "Personalized GLP-1," never naming semaglutide or tirzepatide. It grades C, 5 out of 14 — computed from published terms alone; we hold no affiliate relationship with Wellspring today.

What it is, and who it's for

Wellspring Longevity Clinic is a California-based telehealth service selling NAD+, sermorelin and glutathione alongside GLP-1 and GLP-1/GIP therapy. The GLP-1 products are the euphemism worth noting: the site markets "Personalized GLP-1" and "Personalized GLP-1/GIP" rather than naming semaglutide or tirzepatide anywhere on the treatment page we checked — softer branding than every other GLP-1-selling provider here.

What it actually costs

NAD+: "Starts at $249" Sermorelin: "Starts at $349" Both list "30-day supply of the medication, shipped every 30 days" — a clear billing cadence, at least. What neither page states is what the "Starts at" figure depends on, or what a higher tier costs.

The dedicated Pricing FAQ is where this falls apart. Asked directly — the FAQ page literally has a section titled "Pricing" — Wellspring answers with no number: "Many treatment plans include a free consultation. If a prescription is issued, you can purchase your medication at significantly lower costs than traditional retail prices—often more affordable than your local pharmacy." "Traditional retail prices" is an easy bar (brand-name GLP-1 list prices routinely exceed $1,000/month); it says nothing about what Wellspring itself charges. The one place a reader would look for a straight answer gives a comparison instead.

What each page says, and what it doesn't

QuestionWhat Wellspring answers
"Pricing" (FAQ)No number — a comparison to "traditional retail prices"
NAD+ product page"Starts at $249" — basis for the range not stated
"Which pharmacies do you use?"Rush Pharmacy, named — no 503A/503B classification
CancellationNone — "unable to change or cancel" once submitted
Verified 4 August 2026 on startwellspring.com. The pharmacy is named — just not where a reader would look for it.

Consultation coverage is hedged, not confirmed. "Many treatment plans include a free consultation" — "many," not "all." A reader cannot tell whether their specific plan includes it without asking directly.

There is no cancellation window of any kind. Its own FAQ states: "Orders begin processing immediately after they are placed. As a result, we are unable to change or cancel them once submitted. Medications are not able to be returned or exchanged." Several other providers here offer at least a same-day or 24-hour window; Wellspring offers none.

Clinical oversight and the pharmacy

Here is the one genuine positive worth crediting: Wellspring does name its pharmacy — Rush Pharmacy — when asked directly in its FAQ. "Wellspring Longevity Clinic works with Rush Pharmacy... that meet or exceed all federal and state requirements. We encourage the use of LegitScript or NABP-accredited facilities." That is more disclosure than several higher-graded rows here manage. The catch: it's findable only in one specific FAQ answer, not on any product page, which instead carry only the generic "Medication is compounded and dispensed by a licensed third-party pharmacy" language. No 503A or 503B classification is stated for Rush Pharmacy anywhere we could find.

The evidence behind what it sells

The two products this ranking grades here — NAD+ and sermorelin — sit at very different distances from proof, and neither is close.

A 2026 PRISMA-guided systematic review screened 113 studies including 33 human intervention trials and found that oral NAD+ precursors reliably raise NAD+ levels and are well tolerated, but that effects on functional, metabolic and vascular outcomes were heterogeneous and often null, with clinical effectiveness for anti-aging "inconclusive." Directly relevant to an injectable product: no eligible outcomes trial evaluated intravenous or intramuscular NAD+ itself for anti-aging or wellness1.

Sermorelin is a growth-hormone-releasing analog, and the class raises the hormone while the outcomes remain the open question. The standing systematic review of growth hormone in healthy older adults found small body-composition changes — a little more lean mass, a little less fat — with no demonstrated improvement in the outcomes people buy it for, alongside higher rates of soft-tissue edema, joint pain and impaired fasting glucose2.

Both are compounded, and FDA is explicit that compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before marketing3.

Where it's weak, and who should skip it

Skip it if you need a real number before you're willing to start an intake — the "Starts at" figures are unresolved, and the FAQ page built to answer exactly that question doesn't. Skip it if you might need to change your mind; there's no cancellation window once an order is placed, full stop. If you proceed, ask directly whether your specific plan's consultation is included, and ask for the un-teased monthly price before committing.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). Wellspring takes zero on price transparency — the "Starts at" figures are unresolved and the dedicated Pricing FAQ answer gives no number. It takes the full four for a genuine longevity line: NAD+, sermorelin and glutathione are a real menu, not a single peptide bolted onto GLP-1. Zero for clinical oversight, because "many" plans including a consultation isn't a confirmed inclusion. One of two for pharmacy — Rush Pharmacy is named, just not classified and not surfaced where a reader would actually look. Zero for human support, with no stated ongoing-messaging claim. Five of fourteen: a C.

Two fixes would move this row meaningfully: put a real number on the Pricing FAQ answer instead of a retail comparison, and move the pharmacy name from a buried FAQ item onto the product pages themselves. Neighbors worth reading next are the Revel Health review and System Labs review, both NAD+/peptide providers with different pricing and pharmacy transparency; the full field is at our provider rankings.

Frequently asked questions

How much does Wellspring Longevity Clinic cost?

There's no single confirmed answer. Verified 4 August 2026: individual product pages state a "Starts at" figure — NAD+ from $249/month, Sermorelin from $349/month, both for a 30-day supply shipped every 30 days — but neither page explains what the starting figure depends on. The site's own FAQ page has a section literally titled "Pricing," and its answer gives no number: "Many treatment plans include a free consultation. If a prescription is issued, you can purchase your medication at significantly lower costs than traditional retail prices—often more affordable than your local pharmacy." That's a comparison, not a price.

Does Wellspring Longevity Clinic name its pharmacy?

Yes, but only if you find the right FAQ answer. Every product page carries the same generic disclosure — "Medication is compounded and dispensed by a licensed third-party pharmacy" — with no name. The FAQ page's "Which pharmacies do you use?" entry does name one: "Wellspring Longevity Clinic works with Rush Pharmacy... that meet or exceed all federal and state requirements." No 503A or 503B classification is stated for it anywhere we could find.

Can I cancel an order from Wellspring Longevity Clinic?

No, once it's been placed. The site's FAQ states plainly: "Orders begin processing immediately after they are placed. As a result, we are unable to change or cancel them once submitted. Medications are not able to be returned or exchanged." There is no window at all — several other providers in our ranking offer at least a same-day or 24-hour cancellation period before this point.

References

  1. Gallagher C, Emmanuel OO (2026). NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews. https://pubmed.ncbi.nlm.nih.gov/41655607/
  2. Liu H, Bravata DM, Olkin I, et al. (2007). Systematic review: the safety and efficacy of growth hormone in the healthy elderly.. Annals of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/17227934/
  3. U.S. Food and Drug Administration (2025). Compounding and the FDA: Questions and Answers ('Compounded drugs are not FDA-approved'). FDA — Human Drug Compounding. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.